Paragon Care Limited (ASX:PGC)

Market Cap	306.23M -53.8%
Revenue (ttm)	3.67B +8.5%
Net Income	-13.93M
EPS	-0.01
Shares Out	1.66B
PE Ratio	n/a
Forward PE	11.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	561,040
Open	0.1900
Previous Close	0.1850
Day's Range	0.1900 - 0.1900
52-Week Range	0.1700 - 0.4500
Beta	1.42
RSI	49.89
Earnings Date	May 26, 2026

About Paragon Care

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, b...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2005
• Employees: 550
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PGC

Financial Performance

In fiscal year 2025, Paragon Care's revenue was 3.61 billion, an increase of 21.68% compared to the previous year's 2.97 billion. Earnings were 20.57 million, an increase of 151.52%.